Mesothelioma Lawsuits in 2026, Verdicts, Settlements, and the J&J Talc Fight, What’s Changed

Mesothelioma litigation isn’t slowing down in 2026 — it’s shifting shape entirely. Filings just hit a six-year high, the typical plaintiff looks less like the industrial worker who defined this litigation for fifty years, and Johnson & Johnson’s decade-long fight over talc has swung between the largest verdicts in asbestos-litigation history and a settlement offer that keeps growing by the billion. Here’s where things actually stand, based on the most recent industry data and court outcomes available.

The Filing Numbers: A Six-Year High

According to KCIC’s 2025 Asbestos Litigation Year in Review — a widely cited industry report from the Washington, D.C. consultancy that tracks roughly 90% of all U.S. asbestos personal injury filings — total asbestos lawsuits climbed to 4,244 in 2025, the highest total since before pandemic-era court closures. Mesothelioma cases alone crossed 2,000 for the first time in six years, making up close to half of all asbestos filings nationwide, with lung cancer claims accounting for most of the rest. KCIC called the jump “significant,” noting filings had otherwise trended downward for years before this reversal.

“Asbestos litigation continues to shift, particularly in how exposures are alleged and cases are filed,” said Megan Burns, KCIC’s Senior Managing Director, when the report published in late April 2026. “This report gives stakeholders a clear, data-driven view of those changes and what they may signal going forward.”

Part of that shift is geographic. Illinois expanded its courts’ ability to hear asbestos cases in August 2025, a change KCIC flagged as likely to pull in even more filings, while traditional hotspots like Madison County and St. Clair County actually saw filings soften somewhat in mid-2025 even as Philadelphia and New York City picked up volume.

Talc Has Rewritten Who Files These Lawsuits

The single biggest change in the data is how much of this litigation now runs through talcum powder rather than traditional occupational exposure — insulation, brake pads, shipyards, refineries. In 2019, talc allegations showed up in about 16% of mesothelioma filings. By 2025, that number hit 40%, and talc-only filings — cases where powder is the sole alleged exposure source, with no factory or job site involved — jumped 47% in a single year, the sharpest one-year increase KCIC has recorded.

That shift is changing who the plaintiffs are. Mesothelioma has historically been an occupational disease, and its typical claimant has been a man in his mid-70s. Talc-only cases flip that: 57% of talc-only plaintiffs are women, compared to just 18% of the broader asbestos-claimant population, and they tend to be diagnosed younger. If you or a family member used talcum powder for years and were later diagnosed, that demographic shift is exactly why your case might not fit the profile most people still associate with asbestos litigation — and why it’s worth getting evaluated regardless.

The trial numbers back up why plaintiffs’ firms keep filing talc cases: roughly 90% of talc-related asbestos trials over the past five years have been decided in the plaintiff’s favor.

The Verdicts Driving Headlines

Several 2025–2026 verdicts have reset expectations for what a mesothelioma case can be worth:

• $1.5 billion — A Baltimore jury awarded this to Cherie Craft in December 2025, after she was diagnosed with peritoneal mesothelioma linked to talc-based products. It’s the largest single-plaintiff talc verdict on record.
• $966 million — A Los Angeles jury ordered Johnson & Johnson to pay this to the family of Mae K. Moore in October 2025, finding the company acted with malice after Moore developed mesothelioma from decades of baby powder use. The award included $950 million in punitive damages after jurors found J&J 100% responsible.
• $250 million — Simmons Hanly Conroy secured this verdict for Roby Whittington, a former U.S. Steel worker diagnosed after 30 years on the job — the largest mesothelioma verdict ever against a single defendant outside the talc-ovarian context.
• $51 million — California’s Second District Court of Appeals upheld this verdict against Avon in February 2026, in a case brought by Rita-Ann Chapman over decades of talc-based cosmetics use dating back to childhood.
• $45 million — The Illinois Appellate Court affirmed this verdict against Johnson & Johnson and its spinoff Kenvue in July 2026.
• $34.2 million — A Portland, Oregon jury held John Crane Inc. liable for this amount in a September 2025 mesothelioma verdict tied to industrial gasket exposure.
• $32 million — A Los Angeles jury awarded this to the family of Maria Lozano in June 2026, after Lozano died from mesothelioma linked to J&J baby powder use.
• $10 million — Louisiana jurors awarded this to the family of a New Orleans woman who died from malignant mesothelioma after decades of using J&J talc products.

Not every plaintiff win survives appeal. A $260 million verdict for Kyung Lee, who blamed her mesothelioma on long-term baby powder use, was overturned by an Oregon state judge after initially being awarded in June 2026 — a reminder that even a jury win doesn’t guarantee the final number holds.

The J&J Bankruptcy Saga, End to End

No single company has shaped this litigation’s trajectory more than Johnson & Johnson, and its legal strategy has been anything but straightforward. In September 2024, J&J subsidiary Red River Talc filed for Chapter 11 bankruptcy in Texas — the company’s third attempt at using bankruptcy to resolve talc claims through a maneuver known as the “Texas Two-Step,” after two earlier attempts were dismissed. That filing aimed to lock in an approximately $8 billion settlement, and J&J said it had secured support from roughly 83% of plaintiffs, later adding $1.1 billion to sweeten the deal.

It didn’t survive court scrutiny. A federal bankruptcy judge in Houston dismissed the Red River Talc case in March 2026, ending that settlement attempt entirely. Rather than pursue a fourth bankruptcy filing, J&J chose to fight remaining claims in court and, separately, negotiate directly with plaintiffs’ attorneys outside of bankruptcy.

That negotiation produced a new offer: in July 2026, J&J proposed a $5.5 billion settlement to resolve roughly 76,000 pending ovarian cancer claims tied to talc — a smaller, more targeted deal than the earlier bankruptcy-based proposals, and one that requires law firms representing at least 95% of eligible claimants to sign on before it becomes final. In September 2026, J&J reportedly added another $1.1 billion to the offer to bring holdout plaintiffs’ firms on board. If it clears that 95% threshold, payments are expected to begin in 2027, paid out over roughly 25 years.

It’s worth being precise about what this settlement does and doesn’t cover: J&J has said it already resolved about 95% of filed mesothelioma lawsuits separately, along with state consumer-protection claims and talc-supplier disputes. The $5.5 billion offer is specifically aimed at ovarian cancer claims. Mesothelioma-related talc lawsuits — like several of the verdicts above — continue on their own track, largely unaffected by whether the ovarian cancer settlement closes.

Our earlier coverage of the $966 million Moore verdict and the Pennsylvania J&J talc trial walks through how internal J&J documents have shaped these individual cases, if you want the deeper mechanics behind why juries have been this aggressive.

J&J Isn’t the Only Company Filing for Bankruptcy Over Talc

In August 2026, a Delaware bankruptcy judge approved first-day motions letting Vi-Jon — maker of store-brand talc and personal care products — continue operating while it works through its own Chapter 11 case. Vi-Jon faces 367 mesothelioma and lung cancer claims tied to asbestos-contaminated talc, a much smaller docket than J&J’s but a sign that the talc-liability wave is reaching well beyond the biggest name in the space. Companies including Colgate-Palmolive, Cyprus Mines, Whittaker Clark & Daniels, and Imerys Talc America have faced similar claims and, in some cases, their own bankruptcy proceedings.

What Compensation Actually Looks Like Right Now

Two separate systems exist for recovering money in these cases, and they pay very differently.

Bankruptcy trust funds: Companies that filed for bankruptcy decades ago set aside asbestos trust funds specifically to pay future claimants. More than $30 billion collectively sits across over 60 active trusts today. Because individual trust payouts are relatively modest, most claimants file with multiple trusts at once; combined multi-trust filings typically return somewhere in the $300,000–$400,000 range.

Lawsuit settlements and verdicts: For live litigation against companies that haven’t filed bankruptcy, negotiated settlements typically land between $1 million and $2 million, according to recent industry reporting drawing on Mealey’s Litigation Report data — though ranges as tight as $1 million to $1.4 million and as wide as up to $2.4 million appear across different reporting periods. Trial verdicts run far higher on average, with figures cited between $5 million and $11.4 million, before accounting for the outlier billion-dollar awards above. Fewer than 5% of mesothelioma cases actually reach a jury; the overwhelming majority settle.

Attorney fees on these cases typically run 33% to 40% for lawsuits pursued on contingency, and closer to 25% for trust fund claims — meaning a $1.2 million settlement often nets somewhere around $720,000 to $804,000 for the client before case expenses are deducted.

What This Means If You’ve Been Diagnosed

A mesothelioma diagnosis comes with a genuinely urgent legal clock most people don’t expect. Every state sets its own statute of limitations for filing — in some states as short as one year from diagnosis — and that deadline typically doesn’t wait for you to figure out exactly where your exposure came from. Given how much the talc-driven cases above show exposure sources people never suspected (childhood cosmetics use, a parent’s work clothes, a product sitting in a bathroom cabinet for decades), it’s worth having a case evaluated even if you can’t immediately point to an asbestos-heavy job site in your past.

Pursuing a trust fund claim and a lawsuit aren’t mutually exclusive — many claimants do both in parallel, since trust claims move faster but pay less, and lawsuits take longer but can pay significantly more if a company hasn’t filed bankruptcy. For background on how a talc-specific claim actually gets built and argued in court, our coverage of the FDA testimony on J&J’s talc risk disclosures and our broader mesothelioma lawsuits overview both go into what the legal process typically involves.

Frequently Asked Questions

Is mesothelioma litigation increasing or decreasing in 2026?

 Increasing. KCIC’s 2025 data shows the highest filing total since before the pandemic, driven largely by a surge in talc-related claims rather than traditional occupational exposure.

Is the J&J talc settlement final? 

No. The $5.5 billion ovarian cancer settlement proposed in July 2026 (since raised by another $1.1 billion) still requires law firms representing 95% of eligible claimants to opt in before it takes effect. It also doesn’t cover mesothelioma claims, which continue separately.

How much does a typical mesothelioma settlement pay?

Most negotiated settlements fall between roughly $1 million and $2 million, while jury verdicts average considerably higher — though recent billion-dollar-plus outlier verdicts show how far above average a single case can go.

Can I still file if my exposure was decades ago? 

Often yes, since mesothelioma frequently isn’t diagnosed until 20–50 years after exposure, and most states’ filing clocks start at diagnosis rather than exposure. State deadlines vary significantly, so timing should be confirmed with an attorney as soon as possible after diagnosis.

Sources Used in This Article

• KCIC, “2025 Asbestos Litigation Year in Review,” released April 29, 2026: https://www.kcic.com/asbestos/
• Fortune, “Johnson & Johnson proposes $5.5 billion talc settlement after $9 billion deal shot down by bankruptcy court,” July 29, 2026: https://fortune.com/2026/07/29/jj-talc-settlement-no-evidence-5-5-billion/
• Endpoints News, “J&J proposes $5.5B talc settlement,” July 28, 2026: https://endpoints.news/jj-proposes-5-5b-talc-settlement/

Researched and written by Israr Ahmad, legal content researcher and founder of AllAboutLawyer.com. Verdict and settlement figures reflect the most recent industry and court reporting available as of publication and are subject to appeal or change. Last Updated: September 7, 2026.

Disclaimer: This article is for informational purposes only and does not constitute legal advice. Laws vary by state and individual circumstances differ. For advice about your specific situation, consult a qualified attorney.